Global Medical Director at Basilea Pharmaceutica Ltd, Allschwil

Allschwil, Basel-Landschaft, Switzerland -

Full Time

Start Date

Immediate

Expiry Date

02 Sep, 26

Salary

0.0

Posted On

04 Jun, 26

Experience

2 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Medical Monitoring, Clinical Development, Safety Oversight, Infectious Diseases, Regulatory Interactions, Strategic Planning, Clinical Trial Management, Medical Data Review, Risk Indicator Monitoring, Protocol Review, Health Authority Representation, Advisory Board Leadership, Scientific Exchange, Medical Statistics, Portfolio Planning, Cross-functional Collaboration

Industry

Biotechnology Research

Description

We are looking for... ....a highly motivated Global Medical Director for our Clinical Development department for our headquarter in Allschwil, Switzerland. Your tasks Serve as Medical Director for the ongoing Fosmanogepix Phase III programme, providing leadership in safety oversight, eligibility assessment, medical data review, query resolution, risk indicator monitoring, blinding oversight, and protocol/document review. Ensure robust oversight of external medical monitoring activities at Clinical Research Organisations and manage external consultants Build and maintain investigator networks to accelerate enrolment in the Fosmanogepix Phase III programme, working closely with the Clinical Study Team Contribute to strategic planning, including Fosmanogepix positioning, clinical development plans, and competitor analysis Support the Fosmanogepix Expanded Access Program Act as a key medical interface with the Medical and Global Affairs department to ensure alignment and collaboration Support portfolio planning for selected programmes, providing medical expertise to guide decision-making Drive process improvements and innovation, delivering efficiency gains and scalable solutions for clinical development activities Prepare for and actively participate in health authority meetings, ensuring high-quality medical input and representation Serve as the internal and external subject matter expert on medical issues related to assigned development products Lead advisory boards and engage with key investigators, fostering scientific exchange and collaboration Contribute to company publications and support external scientific projects to advance knowledge and visibility Provide cross-functional medical support, advising on clinical development aspects for Communications, Commercial, and other relevant functions Your profile Medical Degree (MD) with clinical experience in a hospital setting. Strong expertise in Infectious Diseases; formal training (e.g., Facharzt, Fellowship, or equivalent) is highly desirable Hands-on experience managing severe infections, such as invasive fungal infections or infections caused by drug-resistant pathogens, is an advantage Industry experience in Clinical Development, particularly with antibiotics and/or antifungals, is preferred but not essential Familiarity with regulatory interactions and health authority processes would be beneficial Additional training in medical statistics is an asset Fluency in English is required; proficiency in other languages is an advantage Why us? Basilea is committed to putting people first. In addition to competitive remuneration, we offer the opportunity to work on inspiring, cross-functional projects in an engaging working environment. We strongly believe that every employee can make an impact and is vital to our success. If you wish to become part of a company that strives to make a difference to the lives of patients worldwide, we are looking forward to receiving your application via e-mail to basilea@coulterpartners.com. Additional information can be found on our website www.basilea.com. Please note About us Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea has about 190 employees. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands, Cresemba® for the treatment of invasive fungal infections and Zevtera® for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN).

Responsibilities

Lead the medical oversight of the Fosmanogepix Phase III programme, including safety monitoring, data review, and investigator network management. Provide strategic medical expertise for portfolio planning, health authority interactions, and cross-functional support across the organization.